- $4.67bn
- $5.50bn
- $8.87bn
- 85
- 93
- 49
- 90
Annual cashflow statement for Nov, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2,537 | -245 | 155 | 985 | 635 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2,647 | 179 | 126 | -71 | 62 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 529 | 40 | -759 | -584 | 215 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 926 | 291 | -179 | 143 | 1,304 |
| Capital Expenditures | -226 | -201 | -214 | -283 | -351 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 82 | 5 | -24 | -10 | -120 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -144 | -196 | -238 | -293 | -471 |
| Financing Cash Flow Items | -28 | -20 | -10 | 7 | -30 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -259 | -189 | -96 | -103 | -406 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 521 | -101 | -522 | -253 | 414 |